title: High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer.
authors.affiliation: Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
authors.forename: E J
authors.initials: EJ
authors.lastname: Shpall
authors.forename: D
authors.initials: D
authors.lastname: Clarke-Pearson
authors.forename: J T
authors.initials: JT
authors.lastname: Soper
authors.forename: A
authors.initials: A
authors.lastname: Berchuck
authors.forename: R B
authors.initials: RB
authors.lastname: Jones
authors.forename: R C
authors.initials: RC
authors.lastname: Bast
authors.forename: M
authors.initials: M
authors.lastname: Ross
authors.forename: Y
authors.initials: Y
authors.lastname: Lidor
authors.forename: K
authors.initials: K
authors.lastname: Vanacek
authors.forename: T
authors.initials: T
authors.lastname: Tyler
mesh_terms: D000328:Adult; D000477:Alkylating Agents / Q000627:therapeutic use*; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood; D016026:Bone Marrow Transplantation; D002945:Cisplatin / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000009:adverse effects; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000378:metabolism / Q000628:therapy*; D013852:Thiotepa / Q000627:therapeutic use; D014182:Transplantation, Autologous
chemical_list: D000477:Alkylating Agents; D015295:Antigens, Tumor-Associated, Carbohydrate; D003520:Cyclophosphamide; D013852:Thiotepa; D002945:Cisplatin